Related Experiment Video
Updated: Jun 28, 2026

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
Published on: September 15, 2023
Gamma-tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple-signalling pathways
1Davos Life Science Pte. Ltd., Cancer Research Laboratory, 11 Biopolis way, #07-03, The Helios 138667, Singapore.
Abstract:
Tocotrienol-rich fraction (TRF) has demonstrated antiproliferative effect on prostate cancer (PCa) cells. To elucidate this anticancer property in PCa cells, this study aimed, first, to identify the most potent isomer for eliminating PCa cells; and second, to decipher the molecular pathway responsible for its activity. Results showed that the inhibitory effect of gamma-tocotrienol was most potent, which resulted in induction of apoptosis as evidenced by activation of pro-caspases and the presence of sub-G(1) cell population. Examination of the pro-survival genes revealed that the gamma-tocotrienol-induced cell death was associated with suppression of NF-kappaB, EGF-R and Id family proteins (Id1 and Id3). Meanwhile, gamma-tocotrienol treatment also resulted in the induction of JNK-signalling pathway and inhibition of JNK activity by a specific inhibitor (SP600125) was able to partially block the effect of gamma-tocotrienol. Interestingly, gamma-tocotrienol treatment led to suppression of mesenchymal markers and the restoration of E-cadherin and gamma-catenin expression, which was associated with suppression of cell invasion capability. Furthermore, a synergistic effect was observed when cells were co-treated with gamma-tocotrienol and Docetaxel. Our results suggested that the antiproliferative effect of gamma-tocotrienol act through multiple-signalling pathways, and demonstrated for the first time the anti-invasion and chemosensitisation effect of gamma-tocotrienol against PCa cells.
Insights
Gamma-tocotrienol shows potent anticancer effects on prostate cancer (PCa) cells by inducing apoptosis and suppressing key survival pathways. It also inhibits invasion and enhances chemotherapy effectiveness.
Area of Science:
- Oncology
- Molecular Biology
- Nutritional Science
Background:
- Prostate cancer (PCa) remains a significant health concern.
- Tocotrienol-rich fraction (TRF) has shown potential antiproliferative effects on PCa cells.
- Identifying specific isomers and their mechanisms is crucial for therapeutic development.
Purpose of the Study:
- To identify the most potent tocotrienol isomer against PCa cells.
- To elucidate the molecular pathways underlying gamma-tocotrienol's anticancer activity.
- To evaluate the anti-invasion and chemosensitization potential of gamma-tocotrienol.
Main Methods:
- In vitro studies using PCa cell lines.
- Apoptosis assays (pro-caspase activation, sub-G1 population).
- Analysis of signaling pathways (NF-kappaB, EGF-R, Id proteins, JNK) and gene expression (mesenchymal markers, E-cadherin, gamma-catenin).
- Combination treatment with gamma-tocotrienol and Docetaxel.
Main Results:
- Gamma-tocotrienol demonstrated the most potent antiproliferative and apoptosis-inducing effects.
- Cell death was linked to the suppression of NF-kappaB, EGF-R, Id1, and Id3.
- Gamma-tocotrienol activated the JNK signaling pathway.
- Suppression of mesenchymal markers and restoration of E-cadherin/gamma-catenin reduced cell invasion.
- Synergistic effects observed with Docetaxel co-treatment.
Conclusions:
- Gamma-tocotrienol exhibits potent anticancer properties against prostate cancer via multiple signaling pathways.
- It possesses significant anti-invasion and chemosensitization capabilities.
- Gamma-tocotrienol represents a promising therapeutic agent for prostate cancer treatment.
Related Concept Videos
TGF - β Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

